S. Kehoe

Most-cited papers

1. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.

   S. Kehoe, J. Hook, M. Nankivell, G. Jayson +13 more

   2015The Lancet1,286 citations

   Semantic Scholar

   Save

2. FIGO staging of endometrial cancer: 2023

   J. Berek, X. Matías-Guiu, C. Creutzberg, C. Fotopoulou +5 more

   2023International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics1,046 citations Open access

   Semantic Scholar

   Save

3. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update

   J. Berek, M. Renz, S. Kehoe, L. Kumar +1 more

   2021International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics459 citations Open access

   Semantic Scholar

   Save

4. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.

   I. Vergote, C. Coens, M. Nankivell, G. Kristensen +134 more

   2018The Lancet Oncology270 citations Open access

   Semantic Scholar

   Save

5. The TNM classification of malignant tumours—towards common understanding and reasonable expectations

   B. O'Sullivan, J. Brierley, D. Byrd, F. Bosman +6 more

   2017The Lancet Oncology253 citations Open access

   Semantic Scholar

   Save

6. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.

   S. Coleridge, Andrew Bryant, Thomas J Lyons, R. Goodall +2 more

   2019Cochrane Database of Systematic Reviews220 citations Open access

   Semantic Scholar

   Save

7. Worldwide initiatives to eliminate cervical cancer

   S. Wilailak, M. Kengsakul, S. Kehoe

   2021International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics110 citations Open access

   Semantic Scholar

   Save

8. Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.

   S. Coleridge, A. Bryant, S. Kehoe, J. Morrison

   2021Cochrane Database of Systematic Reviews101 citations Open access

   Semantic Scholar

   Save

9. British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice.

   C. Fotopoulou, M. Hall, D. Cruickshank, H. Gabra +8 more

   2017European Journal of Obstetrics, Gynecology, and Reproductive Biology95 citations Open access

   Semantic Scholar

   Save

10. Chemotherapy or upfront surgery for newly diagnosed advanced ovarian cancer: Results from the MRC CHORUS trial.

    S. Kehoe, J. Hook, M. Nankivell, G. Jayson +13 more

    201393 citations

    Semantic Scholar

    Save

11. An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor

    M. Gore, A. Hackshaw, W. Brady, R. Penson +18 more

    2019Gynecologic Oncology86 citations Open access

    Semantic Scholar

    Save

12. Progress in clinical research in surgery and IDEAL.

    P. McCulloch, J. Feinberg, Y. Philippou, A. Kolias +6 more

    2018The Lancet83 citations Open access

    Semantic Scholar

    Save

13. Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide.

    Naveena Singh, C. Gilks, L. Hirschowitz, S. Kehoe +5 more

    2016Gynecologic Oncology66 citations Open access

    Semantic Scholar

    Save

14. Repurposing itraconazole for the treatment of cancer.

    R. Pounds, S. Leonard, C. Dawson, S. Kehoe

    2017Oncology Letters61 citations Open access

    Semantic Scholar

    Save

15. Adjacent Lichen Sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma.

    J. Yap, R. Fox, S. Leonard, R. Ganesan +4 more

    2016Gynecologic Oncology57 citations

    Semantic Scholar

    Save

16. Diagnosis of ovarian cancer

    S. Sundar, R. Neal, S. Kehoe

    2015British medical journal54 citations Open access

    Semantic Scholar

    Save

17. Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer.

    A. Phillips, S. Sundar, Kavita Singh, J. Nevin +3 more

    2018European Journal of Surgical Oncology47 citations Open access

    Semantic Scholar

    Save

18. Surgical and systemic management of endometrial cancer: an international survey

    C. Fotopoulou, R. Kraetschell, S. Dowdy, K. Fujiwara +11 more

    2014Archives of Gynecology and Obstetrics37 citations Open access

    Semantic Scholar

    Save

19. Position statement on ethics, equipoise and research on charged particle radiation therapy

    M. Sheehan, C. Timlin, K. Peach, A. Binik +24 more

    2013Journal of Medical Ethics36 citations Open access

    Semantic Scholar

    Save

20. Primary Surgery or Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: The Debate Continues….

    A. Leary, R. Cowan, D. Chi, S. Kehoe +1 more

    2016American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting35 citations

    Semantic Scholar

    Save

21. Multicentre trial of carboplatin/paclitaxel versus oxaliplatin/capecitabine, each with/without bevacizumab, as first line chemotherapy for patients with mucinous epithelial ovarian cancer (mEOC).

    M. Gore, A. Hackshaw, W. Brady, R. Penson +16 more

    201533 citations

    Semantic Scholar

    Save

22. FIGO staging in ovarian carcinoma and histological subtypes

    S. Kehoe

    2020Journal of Gynecologic Oncology28 citations Open access

    Semantic Scholar

    Save

23. Maintaining surgical care delivery during the COVID-19 pandemic: A comparative cohort study at a tertiary gynecological cancer centre

    E. Leung, Zahra Pervaiz, J. Lowe‐Zinola, Sian Cree +11 more

    2020Gynecologic Oncology26 citations Open access

    Semantic Scholar

    Save

24. FIGO Cancer Report 2021

    S. Kehoe, N. Bhatla

    2021International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics25 citations Open access

    Semantic Scholar

    Save

25. Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer

    S. Sundar, C. Rick, F. Dowling, P. Au +15 more

    2016BMJ Open25 citations Open access

    Semantic Scholar

    Save

26. The role of frozen sections in gynaecological oncology: survey of practice in the United Kingdom.

    R. Ganesan, L. Brown, S. Kehoe, W. McCluggage +1 more

    2013European Journal of Obstetrics, Gynecology, and Reproductive Biology25 citations

    Semantic Scholar

    Save

27. Over-expression of DNMT3A predicts the risk of recurrent vulvar squamous cell carcinomas.

    S. Leonard, M. Pereira, R. Fox, N. Gordon +5 more

    2016Gynecologic Oncology24 citations Open access

    Semantic Scholar

    Save

28. Reporting 'Denominator' data is essential for benchmarking and quality standards in ovarian cancer.

    A. Phillips, J. Bálega, J. Nevin, Kavita Singh +3 more

    2017Gynecologic Oncology23 citations Open access

    Semantic Scholar

    Save

29. Outcomes following implementation of symptom triggered diagnostic testing for ovarian cancer.

    N. Rai, J. Nevin, G. Downey, P. Abedin +3 more

    2015European Journal of Obstetrics, Gynecology, and Reproductive Biology23 citations

    Semantic Scholar

    Save

30. Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered?

    P. Pathiraja, H. Sandhu, M. Instone, K. Haldar +1 more

    2014Archives of Gynecology and Obstetrics22 citations

    Semantic Scholar

    Save

31. The Major Constituent of Green Tea, Epigallocatechin-3-Gallate (EGCG), Inhibits the Growth of HPV18-Infected Keratinocytes by Stimulating Proteasomal Turnover of the E6 and E7 Oncoproteins

    J. Yap, S. Kehoe, C. Woodman, C. Dawson

    2021Pathogens21 citations Open access

    Semantic Scholar

    Save

32. Primary Surgery or Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: The Debate Continues….

    R. Cowan, D. Chi, S. Kehoe, M. Nankivell +1 more

    2016American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting21 citations

    Semantic Scholar

    Save

33. Diaphragm disease in advanced ovarian cancer: Predictability of pre-operative imaging and safety of surgical intervention.

    R. Pounds, A. Phillips, S. Kehoe, J. Nevin +5 more

    2018European Journal of Obstetrics, Gynecology, and Reproductive Biology19 citations Open access

    Semantic Scholar

    Save

34. Quality of life outcomes following surgery for advanced ovarian cancer: a systematic review and meta-analysis

    Satyam Kumar, Joanna Long, S. Kehoe, S. Sundar +1 more

    2019International Journal of Gynecological Cancer18 citations Open access

    Semantic Scholar

    Save

35. Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer: Results From a Prospective Longitudinal Feasibility Study

    San Soo Hoo, Natalie Marriott, Aimee E. Houlton, J. Nevin +8 more

    2015International Journal of Gynecologic Cancer18 citations Open access

    Semantic Scholar

    Save

36. Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening

    Sheng-Qing Gu, S. Lheureux, A. Sayad, P. Cybulska +13 more

    2021Proceedings of the National Academy of Sciences of the United States of America17 citations Open access

    Semantic Scholar

    Save

37. Population‐based cancer staging for oesophageal, gastric, and pancreatic cancer 2012‐2014: International Cancer Benchmarking Partnership SurvMark‐2

    C. Cabasag, M. Arnold, M. Piñeros, E. Morgan +8 more

    2021International Journal of Cancer17 citations Open access

    Semantic Scholar

    Save

38. Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.

    F. Pérez-López, I. Ceaușu, H. Depypere, S. Kehoe +7 more

    2017Maturitas17 citations Open access

    Semantic Scholar

    Save

39. Serum Albumin as a Predictor of Survival after Interval Debulking Surgery for Advanced Ovarian Cancer (AOC): A Retrospective Study

    D. Dai, J. Bálega, S. Sundar, S. Kehoe +3 more

    2020Journal of investigative surgery16 citations

    Semantic Scholar

    Save

40. Prolonged interruption of chemotherapy in patients undergoing delayed debulking surgery for advanced high grade serous ovarian cancer is associated with a worse prognosis.

    G. Searle, R. Pounds, A. Phillips, S. Kehoe +3 more

    2020Gynecologic Oncology16 citations

    Semantic Scholar

    Save

41. Neoadjuvant chemotherapy for ovarian cancer: do we have enough evidence?

    S. Kehoe

    201516 citations

    Semantic Scholar

    Save

42. The Prognostic Characteristics and Recurrence Patterns of High Grade Endometrioid Endometrial Cancer: A Large Retrospective Analysis of a Tertiary Center

    Andreas Zouridis, K. Zarrindej, J. Rencher, Christina Pappa +11 more

    2023Journal of Clinical Medicine13 citations Open access

    Semantic Scholar

    Save

43. The evolving role of one-step nucleic acid amplification (OSNA) for the intra-operative detection of lymph node metastases: A diagnostic accuracy meta-analysis.

    A. Tranoulis, D. Georgiou, J. Yap, S. Attard-Montalto +5 more

    2020European Journal of Surgical Oncology13 citations

    Semantic Scholar

    Save

44. The role of preoperative computerized tomography (CT) scan of the pelvis and groin in the management of clinically early staged vulva squamous cell carcinoma.

    R. Pounds, D. O’Neill, Kamana Subba, A. Garg +5 more

    2020Gynecologic Oncology12 citations

    Semantic Scholar

    Save

45. Neo-adjuvant chemotherapy for cervical cancer in pregnancy: a case report and literature review.

    R. Dawood, M. Instone, S. Kehoe

    2013European Journal of Obstetrics, Gynecology, and Reproductive Biology12 citations

    Semantic Scholar

    Save

46. Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy

    A. Phillips, S. Kehoe, Kavita Singh, A. Elattar +7 more

    2019Archives of Gynecology and Obstetrics11 citations

    Semantic Scholar

    Save

47. The Impact of Saphenous Vein Sparing During Inguinal Lymphadenectomy on Postoperative Morbidity in Women With Vulval Cancer: An Updated Per-Groin Meta-analysis of Short-term Outcomes

    A. Tranoulis, A. Laios, G. Theophilou, K. Bramis +1 more

    2018International Journal of Gynecologic Cancer10 citations Open access

    Semantic Scholar

    Save

48. Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer

    A. Phillips, Kavita Singh, R. Pounds, S. Sundar +4 more

    2017Journal of Obstetrics and Gynaecology Research9 citations

    Semantic Scholar

    Save

49. Primary chemotherapy versus primary surgery for ovarian cancer - Authors' reply.

    S. Kehoe, M. Nankivell

    2015The Lancet9 citations

    Semantic Scholar

    Save

50. Preoperative Prediction of Lymph Nodal Metastases in Endometrial Carcinoma: Is it Possible?

    R. Fares, S. Kehoe, N. Shams

    2017International Journal of Gynecologic Cancer8 citations Open access

    Semantic Scholar

    Save